Conversion in a Resectable Tumor after Denosumab Neoadjuvant in a Large Dorsal Giant Cells Tumor: A Case Report and a Literature Review
Current Oncology · 2023
DOI: 10.3390/curroncol30100675 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, 2023. Verfasst von María Sereno und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Infanta Sofía University Hospital, Europe Avenue 32, San Sebastián de los Reyes, 28702 Madrid, Spain. Hauptthemen laut MEDLINE: Bone Density Conservation Agents, Giant Cell Tumor of Bone, Spinal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Giant cell tumors of bone are a rare entity, usually occurring in young patients and characteristically arising in the long bones. The spinal location is rare and usually presents with pain and/or neurological symptoms. The treatment of choice is surgery. Treatment with Denosumab, a bisphosphonate inhibitor of RANK-L, which is highly expressed in these tumors, has shown extensive activity in unresectable patients or those undergoing incomplete surgery. Preoperative treatment with this drug is gaining increasing interest, as its high potency in tumor reduction in this subtype of neoplasm has allowed resectability in selected patients. We present the case of a young patient with a large spinal tumor who, after neoadjuvant Denosumab, underwent complete en bloc surgery with clean margins and a great pathological response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Oncology Department, Infanta Sofía University Hospital, Europe Avenue 32, San Sebastián de los Reyes, 28702 Madrid, Spain.
- European University of Madrid, Medicine Departtment, Calle Tajo 1, Villaviciosa de Odón, 28745 Madrid, Spain.
- FIIB HUIS HHEN, 28703 Madrid, Spain.
- Precision Nutrition and Cancer Program, Clinical Oncology Group, IMDEA Food Institute, CEI UAM, CSIC, 28049 Madrid, Spain.
- Neurosurgeon, Neurosurgery Department, Puerta de Hierro University Hospital, C. Joaquín Rodrigo, 1, Majadahonda, 28222 Madrid, Spain.
- Thoracic Surgery Department, Puerta de Hierro University Hospital, C. Joaquín Rodrigo, 1, Majadahonda, 28222 Madrid, Spain.
Zitieren
APA
Sereno, M., Franco, S. R., de la Reina, L., Campo-Cañaveral de la Cruz, J. L., Muñoz de Legaría, M., & Casado Saénz, E. (2023). Conversion in a Resectable Tumor after Denosumab Neoadjuvant in a Large Dorsal Giant Cells Tumor: A Case Report and a Literature Review. Current Oncology. https://doi.org/10.3390/curroncol30100675
Vancouver
Sereno M, Franco SR, de la Reina L, Campo-Cañaveral de la Cruz JL, Muñoz de Legaría M, Casado Saénz E. Conversion in a Resectable Tumor after Denosumab Neoadjuvant in a Large Dorsal Giant Cells Tumor: A Case Report and a Literature Review. Current Oncology. 2023. doi:10.3390/curroncol30100675
BibTeX
@article{Sereno2023,
author = {Sereno, María and Franco, Silvia Roa and de la Reina, Laura and Campo-Cañaveral de la Cruz, José Luis and Muñoz de Legaría, Marta and Casado Saénz, Enrique},
title = {Conversion in a Resectable Tumor after Denosumab Neoadjuvant in a Large Dorsal Giant Cells Tumor: A Case Report and a Literature Review},
journal = {Current Oncology},
year = {2023},
doi = {10.3390/curroncol30100675}
}
EUVIMED